ATE474572T1 - Heilung von wunden - Google Patents

Heilung von wunden

Info

Publication number
ATE474572T1
ATE474572T1 AT01996012T AT01996012T ATE474572T1 AT E474572 T1 ATE474572 T1 AT E474572T1 AT 01996012 T AT01996012 T AT 01996012T AT 01996012 T AT01996012 T AT 01996012T AT E474572 T1 ATE474572 T1 AT E474572T1
Authority
AT
Austria
Prior art keywords
healing
wounds
site
salve
topiramate
Prior art date
Application number
AT01996012T
Other languages
English (en)
Inventor
Nathan Shapira
Mary Lessig
Daniel Driscoll
Original Assignee
Novodermix Internat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novodermix Internat Ltd filed Critical Novodermix Internat Ltd
Application granted granted Critical
Publication of ATE474572T1 publication Critical patent/ATE474572T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01996012T 2000-11-30 2001-11-30 Heilung von wunden ATE474572T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25011300P 2000-11-30 2000-11-30
PCT/US2001/044923 WO2002043731A2 (en) 2000-11-30 2001-11-30 Treatments for neurogenetic disorders, impulse control disorders, and wound healing

Publications (1)

Publication Number Publication Date
ATE474572T1 true ATE474572T1 (de) 2010-08-15

Family

ID=22946345

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01996012T ATE474572T1 (de) 2000-11-30 2001-11-30 Heilung von wunden

Country Status (7)

Country Link
US (3) US20020082222A1 (de)
EP (1) EP1345602B1 (de)
AT (1) ATE474572T1 (de)
AU (1) AU2002227052A1 (de)
CA (1) CA2430010A1 (de)
DE (1) DE60142632D1 (de)
WO (1) WO2002043731A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1345602B1 (de) * 2000-11-30 2010-07-21 Novodermix International Limited Heilung von wunden
US6462084B1 (en) * 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
US20040014681A1 (en) * 2002-05-14 2004-01-22 Ralph Ryback Method for treating dermatoses and tissue damage
AU2003297639A1 (en) * 2002-12-02 2004-06-23 University Of Florida Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases
WO2008027557A2 (en) 2006-08-31 2008-03-06 Spherics, Inc. Topiramate compositions and methods of enhancing its bioavailability
US8298576B2 (en) 2006-11-17 2012-10-30 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
MX2009003911A (es) 2006-12-04 2009-05-28 Supernus Pharmaceuticals Inc Formulaciones de liberacion inmediata, mejoradas de topiramato.
CN102056541B (zh) 2008-06-12 2014-09-24 阿密格德勒有限公司 运动机能减退和/或运动机能亢进状态的检测
CN102256602A (zh) * 2008-10-21 2011-11-23 诺沃德米克斯国际有限公司 用于治疗上皮组织的组合物
US8598235B2 (en) 2009-12-04 2013-12-03 Jon E. Grant Treating impulse control disorders with catechol-O-methyl-transferase inhibitors
TWI570472B (zh) * 2011-10-03 2017-02-11 三菱瓦斯化學股份有限公司 芳香族聚碳酸酯製偏光透鏡
TWI474831B (zh) 2012-09-14 2015-03-01 Univ Taipei Medical 免疫調節蛋白於促進傷口癒合或組織損傷治療的用途
AU2014223313B2 (en) * 2013-03-01 2018-07-19 Global Kinetics Pty Ltd System and method for assessing impulse control disorder
EP3113684B1 (de) 2014-03-03 2020-07-01 Global Kinetics Pty Ltd System zur beurteilung von bewegungssymptomen
EP4541420A3 (de) * 2015-07-17 2025-06-25 Ovid Therapeutics Inc. Verfahren zur behandlung von entwicklungsstörungen mit gaboxadol
BR112022026520A2 (pt) * 2020-06-26 2023-03-07 Univ Do Minho Composição para modulação do folículo piloso, uso de um agente bioativo e kit, produto cosmético, ou reagente

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US892088A (en) * 1907-09-26 1908-06-30 William Rich Marine fire-indicating system and extinguisher.
US5705477A (en) * 1982-09-24 1998-01-06 The United States Of America As Represented By The Department Of Health And Human Services Compositions of transforming growth factor β(TGF-β) which promotes wound healing and methods for their use
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5571521A (en) * 1984-01-16 1996-11-05 Lasker; Sigmund E. Composition containing silver ammonium phenytoin complex and a phenytoin and use of said composition
US5856245A (en) * 1988-03-14 1999-01-05 Nextec Applications, Inc. Articles of barrier webs
US5632727A (en) * 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5646190A (en) * 1991-03-01 1997-07-08 Warner-Lambert Company Acne treating-wound healing compositions and methods for preparing and using same
US5641814A (en) * 1991-03-01 1997-06-24 Warner-Lambert Company Antikeratolytic-wound healing compositions and methods for preparing and using same
US5602183A (en) * 1991-03-01 1997-02-11 Warner-Lambert Company Dermatological wound healing compositions and methods for preparing and using same
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5981606A (en) * 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5658957A (en) * 1991-03-01 1997-08-19 Warner Lambert Company Immunostimulating wound healing compositions and method for preparing and using same
US5663208A (en) * 1991-03-01 1997-09-02 Warner-Lambert Company Antifungal wound healing compositions and methods for preparing and using same
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
US5614561A (en) * 1991-03-01 1997-03-25 Warner-Lambert Company Antihistamine-wound healing compositions and methods for preparing and using same
US5692302A (en) * 1991-03-01 1997-12-02 Warner-Lambert Company Razor cartridges comprising wound healing compositions and methods for preparing and using same
US5648380A (en) * 1991-03-01 1997-07-15 Warner-Lambert Company Anti-inflammatory wound healing compositions and methods for preparing and using same
US5662924A (en) * 1991-03-21 1997-09-02 Smith & Nephew Plc Wound dressing
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US5804213A (en) * 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
CA2123003A1 (en) * 1991-11-06 1993-05-13 Dennis M. Kay Occlusive wound dressing and applicator
USRE36370E (en) * 1992-01-13 1999-11-02 Li; Shu-Tung Resorbable vascular wound dressings
US5376376A (en) * 1992-01-13 1994-12-27 Li; Shu-Tung Resorbable vascular wound dressings
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
WO1993020837A1 (fr) * 1992-04-21 1993-10-28 Ajinomoto Co., Inc. Remede contre les plaies
WO1993021905A1 (en) * 1992-04-23 1993-11-11 Berlex Laboratories, Inc. Bioadhesive solid mineral oil emulsion
GB9212303D0 (en) * 1992-06-10 1992-07-22 Johnson & Johnson Medical Ltd Absorbent products
GB2272645B8 (en) * 1992-11-23 2010-02-10 Johnson & Johnson Medical Wound dressing
GB9225581D0 (en) * 1992-12-08 1993-01-27 Courtaulds Plc Wound dressings
US5902600A (en) * 1992-12-21 1999-05-11 Healthpoint, Ltd. Hydrogel polymer wound dressing
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
GB2275686B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Swellable wound dressing materials
GB2275685B (en) * 1993-03-03 1997-04-30 Johnson & Johnson Medical Water soluble wound dressing materials
US5960795A (en) * 1993-07-16 1999-10-05 Tecnol Medical Products, Inc. Wound covering device
US5955430A (en) * 1993-09-24 1999-09-21 University Of Southern California Use of angiotensin II fragments and analogs thereof in tissue repair
WO1995008565A1 (en) * 1993-09-24 1995-03-30 The University Of Southern California Use of angiotensin ii analogs in tissue repair
AU706333B2 (en) * 1993-09-24 1999-06-17 University Of Southern California Use of angiotensin III and analogs thereof in tissue repair
US5603946A (en) * 1993-10-08 1997-02-18 Bristol-Myers Squibb Company Wound dressing
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5507775A (en) * 1994-01-21 1996-04-16 Progressive Surgical Products Inc. Tissue expansion and approximation device
EP0748215B1 (de) * 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung
WO1995028124A2 (en) * 1994-04-08 1995-10-26 Atrix Laboratories, Inc. An adjunctive polymer system for use with medical device
US5522794A (en) * 1994-06-16 1996-06-04 Hercules Incorporated Method of treating human wounds
US5685834A (en) * 1994-07-29 1997-11-11 Barth; Alan H. Surgical dressing material
US5512041A (en) * 1994-10-07 1996-04-30 Scott Health Care Wound dressing for promoting moist wound healing
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
EP0805662B1 (de) * 1995-01-26 2000-11-02 Advanced Medical Solutions Limited Wundverband
DE69609595T2 (de) * 1995-01-27 2001-04-05 Coloplast A/S, Humlebaek Wundverband mit einem dreidimensionalen teil und verfahren zu seiner herstellung
US5876743A (en) * 1995-03-21 1999-03-02 Den-Mat Corporation Biocompatible adhesion in tissue repair
US5578022A (en) * 1995-04-12 1996-11-26 Scherson; Daniel A. Oxygen producing bandage and method
US5690795A (en) * 1995-06-05 1997-11-25 Applied Materials, Inc. Screwless shield assembly for vacuum processing chambers
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
CA2224253A1 (en) * 1995-06-09 1996-12-27 Martin J. Macphee Chitin hydrogels, methods of their production and use
US6087549A (en) * 1997-09-22 2000-07-11 Argentum International Multilayer laminate wound dressing
KR970027051A (ko) * 1995-11-02 1997-06-24 조규향 카바모일기를 포함하는 신규한 설파메이트 화합물
US5892088A (en) * 1995-11-02 1999-04-06 Yukong Limited Sulfamate compound containing N-substituted carbamoyl group and method for preparing the same
GB9523253D0 (en) * 1995-11-14 1996-01-17 Mediscus Prod Ltd Portable wound treatment apparatus
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
US5968001A (en) * 1996-05-14 1999-10-19 Bristol-Myers Squibb Company Wound dressings with leak prevention seal
US6143037A (en) * 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
RU2207854C2 (ru) * 1996-06-28 2003-07-10 Орто-Макнейл Фармасьютикал, Инк. Способ лечения псориаза
US5753693A (en) 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
US5753694A (en) * 1996-06-28 1998-05-19 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
RU2214241C2 (ru) * 1996-06-28 2003-10-20 Орто-Макнейл Фармасьютикал, Инк. Способ лечения ожирения и способ индуцирования потери веса у млекопитающих
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders
US6033684A (en) * 1996-08-28 2000-03-07 Jonor, Inc. Compositions and methods for wound management
US5807300A (en) * 1996-09-20 1998-09-15 Nix, Jr.; Frank H. Holder for wound dressing
US5897516A (en) * 1996-09-27 1999-04-27 Bristol-Myers Squibb Company Method of treating a wound by monitoring the swelling of a hydrocolloid layer in a wound dressing
CA2267945C (en) * 1996-10-08 2005-05-17 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating neuropathic pain
US6025150A (en) * 1996-11-21 2000-02-15 The Regents Of The University Of Michigan Methods and compositions for wound healing
US5807341A (en) * 1996-12-11 1998-09-15 Team Medical Llc Medical catheter dressing device
US5977428A (en) * 1996-12-20 1999-11-02 Procyte Corporation Absorbent hydrogel particles and use thereof in wound dressings
US5780048A (en) * 1997-03-20 1998-07-14 Lee; Chung Chih First aid bandage dressing system and method of application thereof
US5972332A (en) * 1997-04-16 1999-10-26 The Regents Of The University Of Michigan Wound treatment with keratinocytes on a solid support enclosed in a porous material
US5760006A (en) * 1997-06-23 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating psoriasis
US6136341A (en) * 1998-02-27 2000-10-24 Petito; George D. Collagen containing tissue adhesive
US5989577A (en) * 1998-03-02 1999-11-23 Children's Hospital Medical Center Nontoxic vernix compositions and method of producing
WO2000000130A1 (en) 1998-06-29 2000-01-06 The Procter & Gamble Company Liquid transport member for high flux rates against gravity
AU5429699A (en) 1998-08-19 2000-03-14 Theramark Limited Drug targeting
MXPA01004015A (es) * 1998-10-20 2003-03-10 Johnson & Johnson Derivados anticonvulsivos utiles para el tratamiento de la dependencia, adiccion y abuso del alcohol.
DK1143917T3 (da) * 1998-11-17 2004-06-01 Ortho Mcneil Pharm Inc Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
DE60007078T2 (de) 1999-02-01 2004-12-16 Ortho-Mcneil Pharmaceutical, Inc. Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa
JP2002539088A (ja) * 1999-02-17 2002-11-19 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 本態性振せんを処置するのに有用な抗痙攣性誘導体
ATE294577T1 (de) * 1999-02-24 2005-05-15 Univ Cincinnati Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen
WO2000061138A1 (en) * 1999-04-08 2000-10-19 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
WO2000076493A1 (en) * 1999-06-14 2000-12-21 Thomas Najarian Combination therapy for effecting weight loss and treating obesity
US6515117B2 (en) 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
EP1345602B1 (de) * 2000-11-30 2010-07-21 Novodermix International Limited Heilung von wunden
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
US20040014681A1 (en) * 2002-05-14 2004-01-22 Ralph Ryback Method for treating dermatoses and tissue damage

Also Published As

Publication number Publication date
US8084491B2 (en) 2011-12-27
DE60142632D1 (de) 2010-09-02
AU2002227052A1 (en) 2002-06-11
US20080021094A1 (en) 2008-01-24
EP1345602A2 (de) 2003-09-24
WO2002043731B1 (en) 2003-04-03
EP1345602B1 (de) 2010-07-21
US20020082222A1 (en) 2002-06-27
US20050101543A1 (en) 2005-05-12
CA2430010A1 (en) 2002-06-06
WO2002043731A3 (en) 2003-02-20
WO2002043731A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
DE60142632D1 (de) Heilung von wunden
DK1079807T3 (da) Anvendelse af præparater til tilförsel af antiseptiske midler og/eller midler, som fremmer heling af sår, til de nedre luftveje
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
WO2003018748A3 (en) Anti-cancer and wound healing compounds
EP1587506A4 (de) Verabreichung von capsaicinoiden
DK1227820T3 (da) Oligosaccharidaldonsyrer og topisk anvendelse deraf
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ES2250416T3 (es) Estimulante de secreciohn de hormona de crecimiento.
ATE452640T1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
WO2005034883A3 (en) A method of healing skin wounds in mammals and a composition therefor
DE69902234D1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
BR0001291A (pt) Desfolhante
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
EP1404412A4 (de) Behandlung und zusammensetzung für die wundheilung
SE0004101D0 (sv) New use
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
DK1455849T3 (da) Sårbehandlingsanordning
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
SE0000303D0 (sv) Novel compounds
SE0301885D0 (sv) New use IV
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
MY143194A (en) Topical pharmaceutical compositions for healing wounds
FR2853245B1 (fr) Utilisation du quinquina pour la preparation d'un medicament stimulant l'angiogenese

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties